Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Nutraceutical Supplementation for Male Subfertility
Authors not listed
Hamilton Health Sciences Corporation · 2025
Abstract
Old age, obesity, physical inactivity, environmental factors and genetics may contribute negatively to fertility in both males and females. In males, specifically, certain supplements, such as single antioxidants and trace minerals, have previously been shown to improve sperm function marginally. One hypothesis is that sperm function can be improved even further by combining several different types of supplements (e.g., amino acids, energy carriers, vitamins, antioxidants, and trace minerals) to target several age-related cell pathways, for example, oxidative stress, mitochondrial dysfunction(definition), inflammation and cell energetics. This 3-month placebo-controlled, randomized clinical trial, aims to test the effects of a novel multi-ingredient supplement (Fertility Enhancer) that targets several age-related cell pathways on sperm function in overweight or obese and subfertile males.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2025). Nutraceutical Supplementation for Male Subfertility. <em>Hamilton Health Sciences Corporation</em>. https://clinicaltrials.gov/study/NCT06091969
Vancouver
Anonymous. Nutraceutical Supplementation for Male Subfertility. Hamilton Health Sciences Corporation. 2025.
BibTeX
@misc{anon2025Nutrac,
title = {Nutraceutical Supplementation for Male Subfertility},
author = {Anonymous},
journal = {Hamilton Health Sciences Corporation},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2021
Open access · CC-BY
Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
biorxiv 2024
Preprint · CC-BY
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy
Journal of Molecular Medicine 2011
Open access · CC-BY
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
Biomedicine & Pharmacotherapy 2026
Open access · CC-BY
Telomerase and chronic inflammation as central molecular links in aging
Biomolecules 2023
Open access · CC-BY
Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities
Antioxidants 2021
Open access · CC-BY